Efficiency and safety of subconjunctival injection of anti-VEGF agent – bevacizumab – in treating dry eye
Xiaodan Jiang,* Huibin Lv,* Weiqiang Qiu, Ziyuan Liu, Xuemin Li, Wei Wang Department of Ophthalmology, Peking University Third Hospital, Beijing, People’s Republic of China *These authors contributed equally as first authors Purpose: Dry eye is a chronic inflammatory ocular surfac...
Saved in:
Main Authors: | Jiang X (Author), Lv H (Author), Qiu W (Author), Liu Z (Author), Li X (Author), Wang W (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of intra-meibomian gland injection of the anti-VEGF agent bevacizumab for the treatment of meibomian gland dysfunction with lid-margin vascularity
by: Jiang X, et al.
Published: (2018) -
Update and developments in the treatment of glioblastoma multiforme – focus on bevacizumab
by: Naveed Wagle, et al.
Published: (2010) -
Calcitriol Alleviates Hyperosmotic Stress-Induced Corneal Epithelial Cell Damage via Inhibiting the NLRP3–ASC–Caspase-1–GSDMD Pyroptosis Pathway in Dry Eye Disease
by: Zhang J, et al.
Published: (2021) -
Evaluation of Topical and Subconjunctival Injection of Hyaluronic Acid-Coated Nanoparticles for Drug Delivery to Posterior Eye
by: Cheng-Han Tsai, et al.
Published: (2022) -
An Update Review of Biosimilars of Adalimumab in Psoriasis – Bioequivalence and Interchangeability
by: Zhou X, et al.
Published: (2021)